International Technology Transfer of a GCLP-Compliant HIV-1 Neutralizing Antibody Assay for Human Clinical Trials

PLoS ONE - United States
doi 10.1371/journal.pone.0030963
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Strategies for Inducing Effective Neutralizing Antibody Responses Against HIV-1

Expert Review of Vaccines
Molecular MedicineDrug DiscoveryImmunologyPharmacology
2019English

Structural Basis for Broad HIV-1 Neutralization by a Novel MPER-Specific Human Broadly Neutralizing Antibody

SSRN Electronic Journal
2019English

Crystal Structure of a 3B3 Variant—A Broadly Neutralizing HIV-1 scFv Antibody

Protein Science
BiochemistryMedicineMolecular Biology
2009English

Vertical HIV-1 Transmission: Importance of Neutralizing Antibody Titer and Specificity

Scandinavian Journal of Immunology
MedicineImmunology
2001English

Tandem Bispecific Neutralizing Antibody Eliminates HIV-1 Infection in Humanized Mice

Journal of Clinical Investigation
Medicine
2018English

Identification of a Novel Broadly HIV-1-neutralizing Antibody From a CRF01_AE-infected Chinese Donor

Emerging Microbes and Infections
ImmunologyVirologyMicrobiologyEpidemiologyParasitologyMedicineDrug DiscoveryInfectious Diseases
2018English

Rapid Evolution of the Neutralizing Antibody Response to HIV Type 1 Infection

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2003English

Neutralizing Antibody Responses Drive the Evolution of Human Immunodeficiency Virus Type 1 Envelope During Recent HIV Infection

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2005English

Selection of Peptide Mimics of HIV-1 Epitope Recognized by Neutralizing Antibody VRC01

PLoS ONE
Multidisciplinary
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy